Navigation Links
Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis

and the knowledge of the long-term safety and tolerability of TYSABRI.

The combination of TOUCH, TYGRIS and the pregnancy registry will be the largest long-term follow-up undertaken for an MS therapy, and the companies plan to continue to provide similar updates at upcoming medical meetings.

The companies recently announced that as of mid-April, approximately 12,500 patients have been prescribed TYSABRI worldwide. In both commercial use and clinical trials, there are currently over 10,000 patients on TYSABRI therapy worldwide.

-- In the US, approximately 6,600 patients are on TYSABRI therapy commercially. Approximately 10,000 patients have enrolled in the TOUCH program and 1,500 physicians have enrolled patients.

-- In the EU, approximately 2,500 patients internationally have received TYSABRI infusions commercially, mostly in Germany and the Nordic countries.

-- In clinical trial settings, over 1,000 patients are on TYSABRI therapy.

TYSABRI Efficacy Sustained through Three Years

Patients who participated in the Phase III TYSABRI program were eligible to enroll in an open-label extension study that evaluated the therapy's long-term effects. Included in this were patients from AFFIRM, a randomized, double-blind, placebo-controlled, two-year monotherapy study of TYSABRI that enrolled 942 patients (627 patients on TYSABRI, 315 on placebo). In AFFIRM, TYSABRI reduced the annualized relapse rate in patients with MS by 67% (p<0.001) and the risk of 12-week sustained disability progression by 42% (p<0.001) compared with placebo.

In the intent to treat analysis, the annualized relapse rate for patients treated with TYSABRI over the three-year period was 0.23, translating into an average of one relapse every 4.3 years. The relapse rate also continued to remain low over the three-year treatment period with TYSABRI: 0.27 during the first year; 0.20 during the second year; and 0.15 during the third year (based on 531 patien
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces ... available in its catalogue: Personal ... Trends and Opportunities to 2018 ... The report provides in depth market analysis, ... accident and health insurance segment, including: - ...
(Date:8/20/2014)... 2014 Reportbuyer.com has added a new market ... https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html This report analyzes ... by the following Product Segments: Implantable/Internal Cardiac Defibrillators, and ... the US, Canada , ... Asia-Pacific , Middle East ...
(Date:8/20/2014)... RANCHO MIRAGE, Calif. , Aug. 20, 2014 ... patient named Fernando Davila has been successfully treated ... eating disease", by Dr, Anibal R. Gauto , Medical ... Care Center, at Eisenhower Medical Center in Rancho ... a new treatment pioneered by Dr. John Crew ...
Breaking Medicine Technology:Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14
... Calif., Sept. 12 Bionovo, Inc.,(Nasdaq: BNVI ... in the journal for,the American Society for Pharmacology ... In Vitro Metabolism of,Liquiritigenin, a Bioactive Compound Isolated ... Liquiritigenin is one of the active compounds ...
... a new study, men with,locally recurrent prostate cancer ... treatment option., A Phase III clinical trial ... is investigating the safety and efficacy of High ... recurrent prostate,cancer following failed external beam radiation therapy ...
Cached Medicine Technology:Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study 2
(Date:8/21/2014)... mynt welcomes industry leaders Rob and Tiffanie ... growing company. Since its pre-launch in April, mynt has ... continues to gain momentum leading up to its official ... came into network marketing by chance. Tiffanie worked for ... marketing companies. Tiffanie needed help at one particular distributor ...
(Date:8/21/2014)... August 21, 2014 According to ... Application (Biodegradable polymer, Food & Beverage, Personal care ... (Packaging, Agriculture, Automobile, Electronics, Textile) & Geography - ... lactic acid and polylactic acid markets and segments ... each market, based on their sub-segments, in terms ...
(Date:8/21/2014)... Luis Obispo, CA (PRWEB) August 21, 2014 ... edition of Current Pedorthics, a bi-monthly publication of the Pedorthic ... field of pedorthics. , Bunion Bootie ... an alternative solution for bunion sufferers and their pain. It ... worn in nearly any shoe to eliminate the friction and ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 While golfing ... found it hard to stay focused on his game ... mosquitoes. The constant whine, slapping and continual need to ... innovative methods to stay protected from insects while golfing. ... career in the Financial Services/Investment Banking Industry, decided to ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Atlantic Information ... of ACO Business News and The AIS Report on ... the Blue Cross Blue Shield Association or its member ... the latest report in AIS’s Management Insight Series. ... case studies of two insurers — Horizon Healthcare Services, ...
Breaking Medicine News(10 mins):Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2
... HealthDay Reporter , MONDAY, Nov. 22 (HealthDay News) -- Children ... risk for experiencing a stroke compared with those whose parents, ... The finding stems from a survey of more than 13,000 ... when they were young children or adolescents. "I certainly ...
... mouse is helping researchers learn whether more muscle improves ... looking for ways to counteract the unhealthy effects of ... Medical College of Georgia Vascular Biology Center and co-director ... Obesity increases the risk for cardiovascular disease as well ...
... patients whose treatment is delayed not only become sicker than ... dollars more in care over the first several years of ... get people into care early because they will stay healthier ... M.D., M.P.H., an associate professor of medicine in the Division ...
... , MONDAY, Nov. 22 (HealthDay News) -- The pain of ... foot, elbow and lower back pain, a new study has ... osteoarthritis (OA) patients, aged 45 to 79, about pain in ... ankle or foot. Low back pain was significantly associated ...
... known for his groundbreaking work in biochemistry, received the ... joins an illustrious list of laureates which includes 15 ... his research related to artificial leaves and its creation ... research. This Medal has been awarded since 1921 to ...
... SATURDAY, Nov. 20 (HealthDay News) -- Kidney failure patients ... prescribed had significantly better heart function, overall health and ... finding stems from an analysis that compared the impact ... treatments per week, for three to four hours per ...
Cached Medicine News:Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 2Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 3Health News:Fat yet muscular mouse provides clues to improving cardiovascular health 2Health News:For HIV-positive patients, delayed treatment a costly decision 2Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 2Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 3Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 4Health News:Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna 5Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 2Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 3
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes....
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
... a rack for single- and multichannel ... Racks: Can be steam sterilized at ... with an 8 x 12 row ... specifically designed to ensure proper connection ...
... Universal Softfit(tm) Design to fit most ... Compatibility Biohit Electronic (Limited Draw) ... Multi-Channel 5-50ul Capp Aero 50ul ... Titerman 4908 5-50ul Finnpipette Multi-Channel 5-50ul ...
Medicine Products: